Physician profile
Jennifer Williams
NPI 1518907708
$737.54
in general payments reported to CMS, 2019-2025
20 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $11.60 · 2021: $55.14 · 2022: $93.75 · 2023: $105 · 2024: $124 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $132.38 | 2025 | |
| Pfizer INC. | $95.88 | 2019-2022 | |
| Abbvie INC. | $66.25 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $57.44 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $51.57 | 2019-2025 | |
| Organon LLC | $41.85 | 2023-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $36.70 | 2022 | |
| Merck Sharp & Dohme LLC | $32.52 | 2024-2025 | Gardasil 9, Gardasil |
| Embecta Corp. | $27.07 | 2024 | |
| Dexcom, INC. | $26.49 | 2023 | Dexcom G6 Transmitter |
| Millicent US INC | $24.32 | 2025 | Intrarosa |
| Biogen, INC. | $21.81 | 2025 | Zurzuvae |
| Abbott Laboratories | $21.01 | 2023 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $17.83 | 2024 | Gemtesa |
| Meditrina | $17.77 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $15.72 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.83 | 2019 | |
| Avanos Medical | $13.32 | 2019 | |
| Becton, Dickinson and Company | $12.81 | 2019 | |
| Coopersurgical, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.